Clinical features of incidental mild cognitive impairment and dementia in a population-based study

Geriatrics and Gerontology International

Volumn 17, Issue 5, 2017, Pages 722-729

  Hishikawa, Nozomi ^a   Fukui, Yusuke ^a   Sato, Kota ^a   Yamashita, Toru ^a   Ohta, Yasuyuki ^a   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

apparent cognitive decline; cognitive affective functions; general population; mild cognitive impairment; risk factors

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AFFECT; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; EARLY DIAGNOSIS; EDUCATIONAL STATUS; EXERCISE; FEMALE; FUNCTIONAL STATUS; GERIATRIC DEPRESSION SCALE; HABIT; HUMAN; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NORMAL VALUE; POPULATION RESEARCH; PRIORITY JOURNAL; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; YOUNG ADULT; COGNITION; COGNITIVE DEFECT; HEALTH SURVEY; INCIDENCE; JAPAN; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR;

AGED; COGNITION; COGNITIVE DYSFUNCTION; DEMENTIA; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POPULATION SURVEILLANCE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 84966373163     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/ggi.12778     Document Type: Article

References (30)

1. World Health Organization and Alzheimer's Disease International. Dementia: A Public Health Priority. Geneva: World Health Organization, 2012; 92-93. http://www.who.int/mental_health/publications/dementia_report_2012/en/
2. Vanhanen M, Koivisto K, Moilanen L et al. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006; 67: 843–847.
3. Lopez OL, Jagust WJ, Dulberg C et al. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch Neurol 2003; 60: 1394–1399.
4. Monastero R, Palmer K, Qiu C, Winblad B, Fratiglioni L. Heterogeneity in risk factors for cognitive impairment, no dementia: population-based longitudinal study from the Kungsholmen Project. Am J Geriatr Psychiatry 2007; 15: 60–69.
5. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Carmelli D. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 2001; 58: 643–647.
6. Kivipelto M, Helkala EL, Hänninen T et al. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology 2001; 56: 1683–1689.
7. Tervo S, Kivipelto M, Hänninen T et al. Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord 2004; 17: 196–203.
8. Tokuchi R, Hishikawa N, Kurata T et al. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition. J Neurol Sci 2014; 346: 288–292.
9. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43: 2412–2414.
10. Iwatsubo T. Japanese Alzheimer's Disease Neuroimaging Initiative: present status and future. Alzheimers Dement 2010; 6: 297–299.
11. Mueller SG, Weiner MW, Thal LJ et al. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement 2005; 1: 55–66.
12. Deguchi K, Kono S, Deguchi S et al. A novel useful tool of computerized touch panel-type screening test for evaluating cognitive function of chronic ischemic stroke patients. J Stroke Cerebrovasc Dis 2013; 22: 197–206.
13. Fukui Y, Yamashita T, Hishikawa N et al. Computerized Touch-panel Screening Tests for Detecting Mild Cognitive Impairment and Alzheimer's Disease. Intern Med 2015; 54: 895–902.
14. Kawahara Y, Ikeda Y, Deguchi K et al. Simultaneous assessment of cognitive and affective functions in multiple system atrophy and cortical cerebellar atrophy in relation to computerized touch-panel screening tests. J Neurol Sci 2015; 351: 24–30.
15. Abe K, Yamashita T, Hishikawa N et al. A new simple score (ABS) for assessing behavioral and psychological symptoms of dementia. J Neurol Sci 2015; 350: 14–17.
16. Alegret M, Cuberas-Borrós G, Espinosa A et al. Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment. J Alzheimers Dis 2014; 41: 739–748.
17. Hirao K, Ohnishi T, Hirata Y et al. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage 2005; 28: 1014–1021.
18. Austin AW, Gordon JL, Lavoie KL, Arsenault A, Dasgupta K, Bacon SL. Differential association of insulin resistance with cognitive and somatic symptoms of depression. Diabet Med 2014; 31: 994–1000.
19. Gao L, Matthews FE, Sargeant LA, Brayne C, MRC CFAS. An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: from a population based multi-centre longitudinal study. BMC Public Health 2008; 11: 54.
20. Hishikawa N, Yamashita T, Deguchi K et al. Cognitive and affective functions in diabetic patients associated with diabetes-related factors, white matter abnormality and aging. Eur J Neurol 2015; 22: 313–321.
21. Peila R, Rodriguez BL, White LR, Launer LJ. Fasting insulin and incident dementia in an elderly population of Japanese-American men. Neurology 2004; 63: 228–233.
22. Willette AA, Xu G, Johnson SC et al. Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults. Diabetes Care 2013; 36: 443–449.
23. Yaffe K, Falvey C, Hamilton N et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 2012; 69: 1170–1175.
24. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006; 5: 64–74.
25. Peters ME, Rosenberg PB, Steinberg M et al. Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study. Am J Geriatr Psychiatry 2013; 21: 1116–1124.
26. Ikeda M, Fukuhara R, Shigenobu K et al. Dementia associated mental and behavioural disturbances in elderly people in the community: findings from the first Nakayama study. J Neurol Neurosurg Psychiatry 2004; 75: 146–148.
27. Köhler S, Buntinx F, Palmer K, van den Akker M. Depression, vascular factors, and risk of dementia in primary care: a retrospective cohort study. J Am Geriatr Soc 2015; 63: 692–698.
28. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002; 288: 1475–1483.
29. Palmer K, Berger AK, Monastero R, Winblad B, Bäckman L, Fratiglioni L. Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology 2007; 68: 1596–1602.
30. Hughes TF, Chang CC, Vander Bilt J, Gainguli M. Engagement in reading and hobbies and risk of incident dementia: the MoVIES project. Am J Alzheimers Dis Other Demen 2010; 25: 432–438.